Plné znění - 2/2008 Sb. m. s.

Ministerstvo xxxxxxxxxxxx xxxx sděluje, xx xxx 16. xxxxxxxxx 2007 bylo generálním xxxxxxxxx XXXXXX, xxxxxxxxxxx Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx sportu¹⁾, xxxxxxxx xxxxxxxxx xxxxxx xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx látek x xxxxx xxxxxxx.

Xxxxxxx I xxxxxxxxx x xxxxxxxx x xxxxxxx x článkem 34 xxxx. 3 Úmluvy xxx 1. xxxxx 2008 a xxxxx xxxx xxxxxxxxx x xxxxxxxx i xxx Xxxxxx xxxxxxxxx. Dnem xxxxxx Xxxxxxx X x xxxxxxxx přestává xxxxxx Xxxxxxx I Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx xx xxxxx xxx xxx 2007, vyhlášená xxx č. 59/2007 Xx. x. x.

Xxxxxxxx znění Xxxxxxx X x xxxx xxxxxxx do českého xxxxxx xx vyhlašují xxxxxxxx.

X1. XXXXXXXXXX XXXXX

Xxxxxxxxxx xxxxx jsou xxxxxxxx.

1. ANDROGENNÍ XXXXXXXXXX XXXXXXXX (XXX):

x. Xxxxxxxx * XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-androstendion (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (19-xxxxxxxxxxxxxxxx); bolasteron; xxxxxxxx; xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-metyl-5α-androst-2-en-17β-ol); xxxxxxxxxxx; xxxxxxxxxxxxx (19-xxx-17α-xxxxx-4-xx-17-xx); xxxxxxxxxxxxxx; xxxxxxxxxx; furazabol (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); gestrinon; 4-xxxxxxxxxxxxxxxxxx (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; klostebol; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); metenolom; xxxxxxxxxxx; xxxxxxxxxx (2α, 17α-dimetyl-5α-androstan-3-on-17β-ol); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxx (17β-hydroxy-17α-metylestra-4,9,11-trien-3-on); xxxxxxxxxxxxxxxxx; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); xxxxxxxxxx; norethandrolon; xxxxxxxxxxxx; xxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); quinbolon; xxxxxxxxxx; xxxxxxxxx; 1-xxxxxxxxxxx (17β-xxxxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); trenbolon x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

x. Xxxxxxxxx ** XXX:

Xxxxxxxxxxxxx (androst-5-en-3β,17β-diol), xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX), testosteron x xxxxxxxxxxx xxxxxxxxxx x isomery:

5α-androstan-3α,17α-diol androst-5-en-3β,17α-diol

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3β,17β-xxxx)

5α-xxxxxxxxx-3β,17α-xxxx 5-xxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)

5α-xxxxxxxxx-3β,17β-xxxx xxx-xxxxxxxxxxxxxxxxxx

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17α-xxxx 19-xxxxxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17β-xxxx

V xxxxxxxxx, xxx xxxx xxxx produkovat xxxxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxxx, xxxx xx mít xx xx, xx Xxxxxx xxxxxxxx tuto Xxxxxxxxx látku a xxxx xxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxx xx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx xxxx xxxxxxxxxxx x/xxxx když xx jakýkoli jiný xxxxxxxxx xxxxx xx Xxxxxx Xxxxxxxxx významně xxxxxxxxx xx xxxxxxx xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx x xxxx tak, xx xxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx. Xxxxxx se xxx za xx, xx Vzorek obsahuje Xxxxxxxxx xxxxx x xxxxxxx xxxxxxx, pokud Xxxxxxxxx xxxxxxx, xx xx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx xxxx xxxxxxxxxx x/xxxx příslušný poměr xx Vzorku Xxxxxxxxx xxxxxxxx fyziologickým xxxx xxxxxxxxxxxx stavem.

Bude xx mít xx xx, xx Xxxxxx Xxxxxxxxx obsahuje Xxxxxxxxx xxxxx x laboratoř xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx xx xxxxx xxxxxxxxx a xxx xxxxxxxxx koncentraci, xxxxx xxx podle xxxxxxxxxx xxxxxxxxxx metody (xxxx. XXXX) prokázat, že xx Zakázaná látka xxxxxxxxxx xxxxxx. V xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

Xxxx se xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx xxxxxxxxxxx xx xxxxxxx xxxxxx, xxxxx xx normálně vyskytují x xxxx x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxx xxxxxxxx xxxxxx xxxxxxx Xxxxxxxx látky, xxxx xxxx. porovnání s xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxx xxxxxxx, xxxx xxxx xxxxxxxxx xxxxxxxxx xxxxx X/X xxxxx než xxxxx (4) ku xxxxx (1) x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx původ xxxxx, provede příslušná Xxxxxxxxxxxxx xxxxxxxxxx xxxxx xxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxxx testů xxxx xxxxxxxxxx následných xxxxx.

Xx-xx xxxxxxxxxx xxxxxx xxxxx xxxxxxx, pak xxxxxxxx xxxx xxxxxxxxxx xxxxxx xxxx xxxxxxxxx x ne xxxx xxxxxxxxx. Xxxxx laboratoř xxxxxxx, xx xxxxxxx xxxxxxxxxx analytické xxxxxx (xxxx. XXXX) xxxxxxxx xxxxx Xxxxxxxx látky, xxxx xxxxx xxxxxxxx xxxxx xxxxxxx, x xxxx xx mít xx xx, xx Xxxxxx obsahuje Xxxxxxxxx xxxxx. Xxxxx xxxxxx xxxxxxx spolehlivá xxxxxxxxxx xxxxxx (xxxx. XXXX) x nejsou k xxxxxxxxx minimálně 3 xxxxxxxxx xxxxx, xxxx xxxxxxx xxxxxxxxxxxxxx xxxxxx Xxxxxxxxx xxx, že xxxx xxxxxxxxxx Xxxxxxxxxxxxxx xxxxxxxxxx v xxxxxxxxxxxxx 3 xxxxxxxx xxxxxxx xxxxxxxx bez xxxxxxxxxxx xxxxxxxx. Xxxxxxxx, který xxxxxxxxxx xxxx xxxxxxxxxxxxxx xxxxxx, xxxx xxxxxx xxxx neobvyklý. Xxxxx xxxxxxxxxxxxxx xxxxxx Xxxxxxxxx, xxxxxxxx xxxxxxxxxx testy, xxxx xxxxxxxxxxxx xxxxxxxx, xxxx xx xxx xxxxxxxxx za Xxxxxxxxx xxxxxxxxxxx nález.

X xxxxxxxx vzácných xxxxxxxxxxxxxx xxxxxxxxx xxxx xxx x xxxx trvale xxxxxxx boldenon xxxxxxxxxxx xxxxxx ve velice xxxxxx xxxxxxxxxxxxx (xx/xx). Xxxxx xxxxxxxxx xxxxxx xxxxx nahlásila x xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. IRMS) xxxxxxxxxxx exogenní xxxxx Xxxxxxxx xxxxx, může xxx xxxxxxxxx další xxxxxxx provedením následného xxxxx (xxxxxxxxxx xxxxx).

Xxxxx laboratoř xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx nález 19-xxxxxxxxxxxxxxx, xxxx xx xx xxxxxxxxx za xxxxxxx x xxxxxxxxxxx xxxxx xxxxxxxxxx xxxxxx Xxxxxxxx xxxxx. X xxxxxxx případě xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

X případě, xx Xxxxxxxxx nebude xxxxxxxxxxxxx xxx dalších xxxxxxxxx, xxxx xx xxx xx xx, xx Xxxxxx Xxxxxxxxx xxxxxxxx Xxxxxxxxx látku.

2. Ostatní anabolické xxxxx, xxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxx modulátory androgenových xxxxxxxxx (SARM), xxxxxxx, xxxxxxx, xxxxxxxxxx, xxx xx x xxxxxxxx xxxxx na xx.

X2. XXXXXXX X PŘÍBUZNÉ XXXXX

Následující xxxxx x xxxxxx xxxxxxxxxx xxxxxxx jsou xxxxxxxx:

1. Xxxxxxxxxxxx (EPO);

2. Xxxxxxx hormon (xXX), xxxxxxxx xxxxxxx xxxxxxx xxxxxxx (např. XXX-1), mechanické růstové xxxxxxx (XXX);

3. Xxxxxxxxxxxxx (např. XX, xXX), zakázané xxx x mužů;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x xxxxx látky x xxxxxxxx chemickou xxxxxxxxxx nebo podobnými xxxxxxxxxxxx účinky.

Xxxxx Xxxxxxxxx xxxxxx xxxxxxxx, xx xxxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxx xx xxxxxxxxxxxx stavem, bude xx mít za xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx (xxx xx xxxxxxx xxxx) x xxxxxxxxx, xxx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx či indikátorů x/xxxx xxxxxxxxx poměry xx Xxxxxx Sportovce xxxxxxx xxxxxxxx hodnoty xxxxxxxx xxxxxxxx u xxxx tak, xx xxxxxxxxxxxx normální xxxxxxxxx xxxxxxxx.

Xxxxx laboratoř xxxxxxxxx, xx užití xxxxxxxxxx xxxxxxxxxx xxxxxx, xx Xxxxxxxx xxxxx xx xxxxxxxxxx xxxxxx, xxxx xx mít xx to, xx Xxxxxx xxxxxxxx Zakázanou xxxxx a xxxx xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx.

S3. XXXX-2 XXXXXXXX

Xxxxxxx xxxx-2 xxxxxxxx xxxxxx xxxxxx D- x X-xxxxxxx xxxx xxxxxxxx.

Xxxxxxxx xxxx formoterol, xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxxx, xxx xxxxx xx xxx inhalaci xxxxx xxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxxx.

I xxxx xxxx udělena xxxxxxxx forma xxxxxxxxxxxx xxxxxxx, xxxx xxxxx xxxxxxxxxxx (xxxxx xxxx xxxxxxxxxx) xxxxx xxx 1000 nanogramů x 1 mililitru xxxx xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx nález, xxxxx Xxxxxxxxx xxxxxxxxx, xx xxxxxxxxxx výsledek byl xxxxxxxx xxxxxxxxxxxxx užíváním xxxxxxxxxxx x xxxxxxxx.

X4. XXXXXXXXXXX X XXXXXXXXXX HORMONŮ

Xxxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, xxxxxxxxxx:

2. Xxxxxxxxxx modulátory xxxxxxxxxxxxx xxxxxxxxx (XXXX), xxxxxxxx:

3. Xxxxxxx xxxxxxxxxxxxxx látky xxxxxxxxxx:

4. Xxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx.

X5. DIURETIKA X XXXXXXX MASKOVACÍ XXXXX

Xxxxxxxxx xxxxx xxxx xxxxxxxx. Xxxxxxxx:

Xxxxxxxxx*, epitestosteron, xxxxxxxxxx, xxxxxxxxxx xxxx-xxxxxxxxx (xxxx. xxxxxxxxxx, xxxxxxxxxx), plasmaexpandery (xxxx. xxxxxxx, xxxxxxx, xxxxxxxxxxxxxxxxx) x xxxxx xxxxx s xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxxxxx, amilorid, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, kanrenon, xxxxxxxx xxxxxxxxxx, metolazon, xxxxxxxxxxxxx, xxxxxxxx (např. bendroflumethiazid, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), triamteren x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx účinky (xxxxx xxxxxxxxxxxx, který xxxx xxxxxxxx).

* Terapeutická xxxxxxx xxxx platná, xxxxx moč Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx s prahovou xxxx xxxxxxxxxxx xxxxxxxx xxxx Xxxxxxxx látky (xxxxx).

X1. XXXXXXXXX XXXXXXX XXXXXXX

Zakázané xx xxxxxxxxxxx:

M2. XXXXXXXX X XXXXXXXXX MANIPULACE

M3. XXXXXX XXXXXX

Neterapeutické xxxxxxx xxxxx, genů, xxxxxxxx xxxxxxxx, xxxx xxxxxxxxxx exprese genů, xxxxx mají schopnost xxxxxx xxxxxxxxx xxxxx, xx xxxxxxxx.

X6. STIMULANCIA

Xxxxxxx xxxxxxxxxxx (včetně xxxx xxxxxx xxxxxxxxxx xxxxxxxxx (X- a X-) xxxxxxx) jsou xxxxxxxx, x xxxxxxxx derivátů xxxxxxxxx v případě xxxxxx místního užití x xxxxxxxxxxx zahrnutých xx Xxxxxxxxxxxxxx xxxxxxxx xxx xxx 2008.

Xxxxxxxxxxx xxxxxxxx:

Adrafinil, xxxxxxxxx**, xxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, benzfetamin, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxxx****, xxxxxxxx, xxxxxxxxx, ethylamfetamin, xxxxxxxxxxx, xxxxxxxxxxx, fendimetrazin, fenetylin, xxxxxxxxxxx, fenkamfamin, xxxxxxxx, xxxxxxxxxxx, fenprometamin, xxxxxxxxxxx, xxxxxxxxx, 4-xxxxxxxxxxxxxx (xxxxxxxx), xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxx***, klobenzorex, kokain, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxx (D-), metylefedrin****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, methylfenidát, xxxxxxxx, xxxxxxxxx, niketamid, xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxxxxxxxx, xxxxxxx, pentetrazol, p-methylamfetamin, xxxxxxxxx, xxxxxxxxxxxxxx, selegilin, xxxxxxxxxx, strychnin, tuaminoheptan x xxxxx xxxxx x podobnou chemickou xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx xxxxxxxxx výslovně xxxx xxxxxxxx x xxxxx xxxxxx xxxx xxxxxxxxxx za xxxxxxxxxxx xxxxx xxxxx, xxxxx Xxxxxxxxx prokáže, xx xxxx xxxxxxxxx xxxxxxxxxx x xxxxxxx léčebných xxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxx xx u xxx xxxxx xxxxxxxxxxxxxxx, xx bude xxxxxxx xxxxxxxx jako xxxxxxxxx xxxxx.

X7. XXXXXXXXX

Xxxxxxxxxxx xxxxxxxxx xxxx zakázaná:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), fentanyl x xxxx deriváty, xxxxxxxxxxx, xxxxxxx, xxxxxx, xxxxxxxx, oxymorfon, pentazocin, xxxxxxx.

X8. XXXXXXXXXXX

Xxxxxxxxxxx (xxxx. xxxxx, marihuana) jsou xxxxxxxx.

S9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx glukokortikosteroidy xxxxxxxx orálně, xxxxxxxx, xxxxxxxxxx nebo xxxxxxxxxxxxx xxxxxxxx jsou zakázané. Xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxxx výjimku.

Xxxx xxxxxxx injekční aplikace (xxxxxxxxxxxx, xx okolí xxxxxx, do xxxxx xxxxxx, xxxxxxxxxx, xx xxxx) x xxxxxxxxx xxxxxxxx vyžadují xxxxxxxxx xxxxxxxxxxxxx výjimku x xxxxxxxx xxxx xxxxxxxxx.

Xxxxxxx xxxxxxxxx xxxxxxxx xx potíže xxxxx (xxxxxx xxxxxxxxxxx/xxxxxxxxxx), xxxx, xxxxx, oční, xxxxxx xxxxx xxxxxxx xxxxxx, xxxxxxxx xxx a xxxxx xxxxxx xxxxxxxx x nevyžadují xxxxxx xxxxx xxxxxxxxxxxx xxxxxxx.

X1. XXXXXXX

Xxxxxxx (xxxxxx) xx zakázaný pouze Xxx soutěži v xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx bude xxxxxxxx xxxxxxxx xxxxxxxx x/xxxx xxxxxxxx xxxx. Xxxxxxx xxxxxxx xxx xxxxxxxx xxxxxxxxxxx pravidla (xxxxxxxxxxxxx xxxxxxx) xx xxx xxxxxx xxxxxxxx uvedena x xxxxxxxxx.

∙ Xxxxxxxxxxxx sport (XXX) (0.10 g/l)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxx x parašutismus (XXX) (0.20 g/l)

∙ Xxxxxxxxxxx (FITA, XXX) (0.10 g/l)

∙ Xxxxxxx xxxxxxx (XXXX) xxx xxx xxxxxxxxxx se xxxxxxxx (0.10 x/x)

∙ Motocyklový xxxxx (XXX) (0.10 g/l)

∙ Vodní xxxxxxxxxx (XXX) (0.30 x/x)

∙ Xxxxxxx (XXX) (0.10 x/x)

X2. XXXX-XXXXXXXXX

Xxxxx xxxx jinak určeno, xxxx-xxxxxxxxx jsou xxxxxxxx xxxxx Xxx soutěži x xxxxxxxxxxxxx sportech.

∙ Xxxxxxxxxxxx xxxxx (XXX)

∙ Billiard (XXXX)

∙ Xxxx (XXXX)

∙ Xxxxx (XXX)

∙ Curling (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Jachting (XXXX) - "xxxxx xxxx" - jen xxxxxxxxxxx

∙ Xxxxxxx (XXX)

∙ Xxxxxxx xxxxxx x xxxxxxxxxxxx (XXX)

∙ Lukostřelba (XXXX, XXX) (zakázané xxxx Mimo soutěž)

∙ Xxxxxxxx (XXX) - xxxxx xx xxxxxx x akrobatické xxxxxxxx-xxxxx x X-xxxxx, x snowboard U-rampa x "big xxx"

∙ Moderní pětiboj (XXXX) - xxx xxxxxxxxxx xx xxxxxxxx

∙ Xxxxxxxxxxx sport (XXX)

∙ Xxxxxxxx x xxxxxxx sporty (XXXX, XXX "xxxxx")

∙ Xxxxxxx (XXXX, XXX) (xxxxxxxx xxxx Xxxx xxxxxx)

∙ Xxxxx motorismus (UIM)

∙ Xxxxx (XXXX)

Xxxx-xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxx:

Xxxxxxxxxx, xxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxx, xxxxxxxxxx, labetalol, xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxx, xxxxxxx, oxprenolol, xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxxx, xxx ne s xxxxxxxx xxxxx xx xx

"Specifické xxxxx"* xxxx xxxxxxxxxxx xxxx:

∙ Všichni Beta-2 xxxxxxxx v inhalaci, xxxxx xxxxxxxxxxx (xxxxxxx xxxx glukuronidu) při xxxxxxxx xxxxxx xxx 1000 xx/xx xxxx x xxxxxxxxxxxx (xxxxxxx xx skupině X 1.2 Xxxxxxx xxxxxxxxxx xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, kropropamid, xxxxxxxxxx, xxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxxxxx, p-metylamfetamin, xxxxxxxxxxxx, xxxxxxxxx, norfenefrin, xxxxxxxxx, xxxxxxxxx, oxilofrin, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxx a xxxxxxx xxxxxxx stimulancia neuvedená xxxxxxxx x xxxxxx X6, xxx která Xxxxxxxxx prokáže, že xxxxxxx podmínky xxxxxxx x xxxxxx S6;

∙ Xxxxxxxxxxx;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"X Xxxxxxx xxxxx být vyjmenovány xxxxxxxxxx xxxxx, xxxxx xxxxxxxx umožňuji neúmyslné xxxxxxxx xxxxxxxxxxxxxxx pravidel, xxxxxxx jsou xxxxxxxxx xxxxxxxx x běžných xxxxxxxxx přípravcích, nebo x xxxxx xx xxxxx xxxxxxxxxxxxxxx, xx xxxxx xxxxxxx zneužity xxxx xxxxxxxxx xxxxxxx." Xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx xxxxx xxxx znamenat xxxxxxx xxxxxx xx předpokladu, xx "...Sportovec xxxx xxxxx xxxxxxxx, xx Xxxxxxx specifické xxxxx xxxxxx zamýšleno ke xxxxxxx xxxxxxxxxxx výkonu...".

Xxxxxx xxxxxxx x. 2/2008 Xx. x. x. xxxxx xxxxxxxxx xxxx 31.1.2008.

Xxxxxx předpis x. 2/2008 Xx. m. x. xxx zrušen xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x xxxxxxxxx xx 7.2.2009.

Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx právních xxxxxxxx x xxxxxxxx není xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx shora xxxxxxxxx xxxxxxxx předpisu.